# Linking patient-specific basal MET phosphorylation levels to liver health

**Authors:** Fabian Fröhlich

PMC · DOI: 10.1038/s44320-024-00023-y · 2024-02-16

## TL;DR

This paper shows how combining proteomic data with mathematical models can predict patient outcomes after liver surgery based on their MET phosphorylation levels.

## Contribution

The study introduces a novel approach linking patient-specific MET phosphorylation levels with liver health outcomes using systems medicine.

## Key findings

- Proteomic data and mathematical models were used to infer patient-specific parameters.
- These parameters predict outcomes following liver surgery based on basal MET phosphorylation levels.

## Abstract

Systems medicine aims at enhancing patient outcomes by integrating molecular profiles and computational methods. In their recent study, Klingmüller and colleagues (Burbano de Lara et al, 2024) integrated proteomic data with mathematical models of signal transduction to infer patient-specific parameters that predict patient outcomes following liver surgery.

Integrative systems medicine approaches can help predicting clinical outcomes. In their recent study, Klingmüller and colleagues (Burbano de Lara et al, 2024) integrate proteomic data with dynamic pathway modelling to infer patient-specific parameters that predict patient outcomes after liver surgery.

## Linked entities

- **Proteins:** MET (MET proto-oncogene, receptor tyrosine kinase)

## Full-text entities

- **Genes:** SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10912760/full.md

---
Source: https://tomesphere.com/paper/PMC10912760